Hazlett, Burt & Watson’s GSK GSK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-766
| Closed | -$30K | – | 803 |
|
2025
Q1 | $30K | Sell |
766
-760
| -50% | -$29.8K | 0.01% | 433 |
|
2024
Q4 | $52K | Buy |
1,526
+1
| +0.1% | +$34 | 0.02% | 359 |
|
2024
Q3 | $63K | Buy |
1,525
+1
| +0.1% | +$41 | 0.03% | 327 |
|
2024
Q2 | $58K | Buy |
1,524
+1
| +0.1% | +$38 | 0.03% | 318 |
|
2024
Q1 | $65K | Buy |
1,523
+1
| +0.1% | +$43 | 0.04% | 297 |
|
2023
Q4 | $56K | Buy |
1,522
+1
| +0.1% | +$37 | 0.04% | 290 |
|
2023
Q3 | $56K | Buy |
1,521
+100
| +7% | +$3.68K | 0.04% | 282 |
|
2023
Q2 | $51K | Buy |
1,421
+111
| +8% | +$3.98K | 0.04% | 295 |
|
2023
Q1 | $46K | Buy |
1,310
+650
| +98% | +$22.8K | 0.04% | 289 |
|
2022
Q4 | $23K | Sell |
660
-520
| -44% | -$18.1K | 0.02% | 364 |
|
2022
Q3 | $34K | Hold |
1,180
| – | – | 0.03% | 304 |
|
2022
Q2 | $64K | Hold |
1,180
| – | – | 0.06% | 244 |
|
2022
Q1 | $64K | Buy |
+1,180
| New | +$64K | 0.05% | 253 |
|